ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05223	Non-small cell lung cancer	3/29	66/7206	0.00226205235047
ko05214	Glioma	3/29	79/7206	0.00377444786894
ko01521	EGFR tyrosine kinase inhibitor resistance	3/29	106/7206	0.0085625643989
ko04012	ErbB signaling pathway	3/29	109/7206	0.00924286792212
ko04973	Carbohydrate digestion and absorption	2/29	42/7206	0.0121885443972
ko04666	Fc gamma R-mediated phagocytosis	3/29	122/7206	0.0125525576464
ko00510	N-Glycan biosynthesis	2/29	50/7206	0.0170009956527
ko05033	Nicotine addiction	2/29	56/7206	0.0210577196139
ko04724	Glutamatergic synapse	3/29	152/7206	0.02251066439
ko04080	Neuroactive ligand-receptor interaction	5/29	423/7206	0.0251322864798
ko04728	Dopaminergic synapse	3/29	185/7206	0.0372920546845
ko04370	VEGF signaling pathway	2/29	77/7206	0.0379898735326
ko04010	MAPK signaling pathway	4/29	321/7206	0.038114182779
ko04721	Synaptic vesicle cycle	2/29	80/7206	0.0407263698031
ko05212	Pancreatic cancer	2/29	83/7206	0.04353593988
ko04062	Chemokine signaling pathway	3/29	201/7206	0.0458915748129
ko04662	B cell receptor signaling pathway	2/29	88/7206	0.0483754732218
ko00562	Inositol phosphate metabolism	2/29	89/7206	0.0493662577529